| 12001 | Hypothyroidism | GCST90018642 | 8.35e-05 |
| 12002 | IDP dMRI TBSS L1 Posterior limb of internal capsule L | GCST90004094 | 8.35e-05 |
| 12003 | potassium (mean, inv-norm transformed) | GCST90476307 | 8.33e-05 |
| 12004 | Type 2 diabetes, wide definition | FING00001383 | 8.25e-05 |
| 12005 | CPA1 levels | GCST90468836 | 8.16e-05 |
| 12006 | Pancreas fat | GCST90016675 | 8.16e-05 |
| 12007 | Eye problems/disorders - None of the above | Eyesight | UKBB00000232 | 7.88e-05 |
| 12008 | BA-exvivo lh area entorhinal | GCST90003220 | 7.86e-05 |
| 12009 | PDGF-BB levels | GCST90428430 | 7.78e-05 |
| 12010 | COVID-19 vaccination | GCST90255613 | 7.75e-05 |
| 12011 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T209 | ECGA000209 | 7.73e-05 |
| 12012 | Hypo-osmolality and hyponatraemia | FING00000648 | 7.66e-05 |
| 12013 | Disorders of lacrimal system | FING00000441 | 7.63e-05 |
| 12014 | Inpatient record format - UK HES In Patient (2015 format) | Summary Administration | UKBB00000364 | 7.62e-05 |
| 12015 | aparc-Desikan rh volume cuneus | GCST90002805 | 7.58e-05 |
| 12016 | Hip minimal joint space width | GCST90281365 | 7.58e-05 |
| 12017 | Invitation to complete online 24-hour recall dietary questionnaire, acceptance | Online follow-up - Diet by 24-hour recall | UKBB00000378 | 7.57e-05 |
| 12018 | Cardiovascular diseases (excluding rheumatic etc) | FING00000255 | 7.42e-05 |
| 12019 | Corns and callosities (PheCode 700) | GCST90476196 | 7.42e-05 |
| 12020 | Haemorrhoidal disease | GCST90014033 | 7.40e-05 |
| 12021 | rfMRI amplitudes (ICA100 node 35) | GCST90004623 | 7.40e-05 |
| 12022 | aparc-pial lh area postcentral | GCST90003162 | 7.32e-05 |
| 12023 | Retention of urine | FING00001257 | 7.32e-05 |
| 12024 | All dysplastic lesions of the cervix uteri | FING00000060 | 7.04e-05 |
| 12025 | Body mass index | GCST90025994 | 6.99e-05 |
| 12026 | Benign neoplasm of colon | neoplasms | UKBB00000092 | 6.87e-05 |
| 12027 | BCAM/CDH5 ratio | GCST90313469 | 6.78e-05 |
| 12028 | CES3 levels | GCST90468720 | 6.75e-05 |
| 12029 | FAM171B levels | GCST90469183 | 6.62e-05 |
| 12030 | Venous thromboembolism | GCST90399744 | 6.46e-05 |
| 12031 | CPA1/PRSS2 ratio | GCST90314206 | 6.45e-05 |
| 12032 | Takes medication for Diabetes/sugar? | GCST90475268 | 6.39e-05 |
| 12033 | Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498926 | 6.39e-05 |
| 12034 | Weight (maximum, inv-normal transformed) | GCST90476460 | 6.29e-05 |
| 12035 | Plasma mannonate* levels in chronic kidney disease | GCST90265479 | 6.19e-05 |
| 12036 | TLR4 levels | GCST90470880 | 5.80e-05 |
| 12037 | Liver enzyme levels (gamma-glutamyl transferase) | GCST90013407 | 5.72e-05 |
| 12038 | Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2) | GCST90132969 | 5.70e-05 |
| 12039 | Body mass index | GCST90428119 | 5.66e-05 |
| 12040 | X-08402 levels | GCST90243538 | 5.62e-05 |
| 12041 | Autorefraction - 3mm cylindrical power (left) | Eyesight | UKBB00000062 | 5.62e-05 |
| 12042 | Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418) | GCST90132986 | 5.59e-05 |
| 12043 | FABP1/FABP2 ratio | GCST90314750 | 5.50e-05 |
| 12044 | Gamma glutamyl transferase levels | GCST90278630 | 5.47e-05 |
| 12045 | Fruit intake (weighted GWA) | GCST90267283 | 5.42e-05 |
| 12046 | Left ventricular end diastole inferior wall thickness | GCST90278515 | 5.41e-05 |
| 12047 | Random glucose levels | GCST90271557 | 5.40e-05 |
| 12048 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | GCST90004070 | 5.39e-05 |
| 12049 | Blood cell traits latent factor 22 (white cell) | GCST90559264 | 5.30e-05 |
| 12050 | Prescriptions - anti-malarial | UKBB00000663 | 5.28e-05 |
| 12051 | Prescriptions - quinine bisulfate | anti-malarial | UKBB00000698 | 5.28e-05 |
| 12052 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T478 | ECGA000478 | 5.28e-05 |
| 12053 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T40 | ECGA000040 | 5.11e-05 |
| 12054 | Diastolic blood pressure | GCST90018732 | 5.09e-05 |
| 12055 | TFF2 levels | GCST90470836 | 5.05e-05 |
| 12056 | BA-exvivo lh volume V2 | GCST90002845 | 5.04e-05 |
| 12057 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T27 | ECGA000027 | 4.99e-05 |
| 12058 | Other disorders of breast | FING00001018 | 4.84e-05 |
| 12059 | aparc-Desikan lh thickness lateraloccipital | GCST90003455 | 4.76e-05 |
| 12060 | X-12844 levels | GCST90200523 | 4.72e-05 |
| 12061 | Leg predicted mass (right) | Impedance measures | UKBB00000397 | 4.60e-05 |
| 12062 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15 | ECGA000015 | 4.56e-05 |
| 12063 | IDP dMRI TBSS L3 Anterior limb of internal capsule R | GCST90004187 | 4.51e-05 |
| 12064 | Body mass index (BMI) | Impedance measures | UKBB00000104 | 4.44e-05 |
| 12065 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T18 | ECGA000018 | 4.43e-05 |
| 12066 | Weight (minimum, inv-normal transformed) | GCST90476466 | 4.39e-05 |
| 12067 | aparc-DKTatlas lh area postcentral | GCST90003254 | 4.38e-05 |
| 12068 | Benign neoplasm: Colon | FING00000171 | 4.37e-05 |
| 12069 | aparc-a2009s rh area S-calcarine | GCST90003414 | 4.28e-05 |
| 12070 | All dysplastic lesions of the cervix uteri, vagina or vulva | FING00000061 | 4.22e-05 |
| 12071 | Leg fat-free mass (right) | Impedance measures | UKBB00000394 | 4.15e-05 |
| 12072 | COL4A1 levels | GCST90468818 | 4.05e-05 |
| 12073 | Hip circumference adjusted for BMI | GCST90020028 | 4.03e-05 |
| 12074 | Body mass index (BMI) | Body size measures | UKBB00000103 | 4.01e-05 |
| 12075 | Glaucoma | GCST90468129 | 4.01e-05 |
| 12076 | Leg fat mass (left) | Impedance measures | UKBB00000389 | 3.96e-05 |
| 12077 | 1-margaroyl-2-linoleoyl-GPC (17:0/18:2) metabolite level | GCST90616013 | 3.96e-05 |
| 12078 | Erectile dysfunction | GCST006956 | 3.95e-05 |
| 12079 | Suicide or other Intentional self-harm | FING00001345 | 3.93e-05 |
| 12080 | Cardiovascular delta age (difference between cardiac MRI-predicted and chronological age) | GCST90239748 | 3.87e-05 |
| 12081 | Leg fat mass (right) | Impedance measures | UKBB00000390 | 3.84e-05 |
| 12082 | Weight (UKB data field 21002) | GCST90468183 | 3.84e-05 |
| 12083 | Glucose | Blood biochemistry | UKBB00000288 | 3.81e-05 |
| 12084 | Intraocular pressure (confirmatory factor analysis Factor 26) | GCST90309360 | 3.77e-05 |
| 12085 | Smoking status (standard GWA) | GCST90267302 | 3.76e-05 |
| 12086 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T207 | ECGA000207 | 3.75e-05 |
| 12087 | T1 FreeSurfer DK rh superiorparietal thickness | GCST90385751 | 3.75e-05 |
| 12088 | Urinary incontinence (PheCode 599.4) | GCST90476152 | 3.71e-05 |
| 12089 | BA-exvivo lh area BA3b | GCST90003210 | 3.70e-05 |
| 12090 | Leg fat-free mass (left) | Impedance measures | UKBB00000393 | 3.67e-05 |
| 12091 | Number of correct matches in round | Pairs matching | UKBB00000532 | 3.61e-05 |
| 12092 | Type 2 diabetes with renal manifestations (PheCode 250.22) | GCST90475670 | 3.60e-05 |
| 12093 | Obesity | GCST001475 | 3.57e-05 |
| 12094 | Colorectal cancer | GCST90018588 | 3.55e-05 |
| 12095 | Principal component-derived dietary pattern 42 | GCST90133047 | 3.49e-05 |
| 12096 | Leg predicted mass (left) | Impedance measures | UKBB00000396 | 3.45e-05 |
| 12097 | Gamma glutamyltransferase levels (UKB data field 30730) | GCST90468070 | 3.22e-05 |
| 12098 | Hearing difficulty with background noise | GCST90245775 | 3.18e-05 |
| 12099 | CELA3A/CTRC ratio | GCST90314012 | 3.17e-05 |
| 12100 | Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels | GCST90200017 | 3.14e-05 |
| 12101 | Age at first sexual intercourse | GCST90000045 | 3.03e-05 |
| 12102 | Retinal detachments and defects | sense organs | UKBB00000756 | 2.96e-05 |
| 12103 | Undecenoylcarnitine (C11:1) levels | GCST90200236 | 2.96e-05 |
| 12104 | Blood glucose levels | GCST90025986 | 2.88e-05 |
| 12105 | Breast cancer | GCST90468117 | 2.86e-05 |
| 12106 | CXADR levels | GCST90468922 | 2.82e-05 |
| 12107 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479 | ECGU000479 | 2.81e-05 |
| 12108 | ICD10 N80: Endometriosis | GCST90454213 | 2.81e-05 |
| 12109 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T36 | ECGA000036 | 2.78e-05 |
| 12110 | Trunk fat mass (UKB data field 23128) | GCST90468180 | 2.74e-05 |
| 12111 | Flat foot (PheCode 735.1) | GCST90476248 | 2.72e-05 |
| 12112 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 14) | GCST90320577 | 2.70e-05 |
| 12113 | IGFBPL1 levels | GCST90469533 | 2.63e-05 |
| 12114 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13 | ECGA000013 | 2.63e-05 |
| 12115 | Osteoarthritis of the hip or knee | GCST007092 | 2.62e-05 |
| 12116 | Principal component-derived dietary pattern 32 | GCST90133037 | 2.58e-05 |
| 12117 | Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24) | GCST90309358 | 2.58e-05 |
| 12118 | Arm fat mass (left) | Impedance measures | UKBB00000043 | 2.57e-05 |
| 12119 | Other headache syndromes | FING00001055 | 2.55e-05 |
| 12120 | aseg rh volume Hippocampus | GCST90002641 | 2.54e-05 |
| 12121 | Takes medication for enlarged prostate (Benign prostatic hyperplasia)? | GCST90475262 | 2.46e-05 |
| 12122 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14 | ECGA000014 | 2.45e-05 |
| 12123 | Retinal detachment with retinal defect | sense organs | UKBB00000754 | 2.44e-05 |
| 12124 | aseg global volume VentricleChoroid | GCST90002598 | 2.36e-05 |
| 12125 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T438 | ECGU000438 | 2.34e-05 |
| 12126 | TFF1 levels | GCST90470835 | 2.34e-05 |
| 12127 | Urea | Blood biochemistry | UKBB00000885 | 2.34e-05 |
| 12128 | IDP T1 FAST ROIs R planum temporale | GCST90002542 | 2.30e-05 |
| 12129 | CA2/TGM2 ratio | GCST90313582 | 2.29e-05 |
| 12130 | T1 CAT volume R RightThalamus | GCST90384097 | 2.24e-05 |
| 12131 | Fracture of rib(s), sternum and thoracic spine | FING00000558 | 2.21e-05 |
| 12132 | Whole body fat free mass (UKB data field 23101) | GCST90428120 | 2.21e-05 |
| 12133 | Breast cancer | GCST004988 | 2.20e-05 |
| 12134 | Lysophosphatidylcholine (24:0) [sn2] levels | GCST90024187 | 2.20e-05 |
| 12135 | aparc-a2009s lh area G+S-subcentral | GCST90003300 | 2.20e-05 |
| 12136 | Unspecified/other endometriosis | FING00001404 | 2.18e-05 |
| 12137 | IDP T1 FAST ROIs R occ pole | GCST90002546 | 2.16e-05 |
| 12138 | Beef consumption (UKB data field 1369) | GCST90132997 | 2.11e-05 |
| 12139 | rfMRI amplitudes (ICA25 node 12) | GCST90004579 | 2.07e-05 |
| 12140 | Dermatochalasis (PheCode 374.6) | GCST90475894 | 2.06e-05 |
| 12141 | Whole body fat mass (UKB data field 23100) | GCST90428121 | 2.05e-05 |
| 12142 | IDP T1 SIENAX CSF unnormalised volume | GCST90002429 | 2.02e-05 |
| 12143 | MUC13 levels | GCST90469963 | 2.00e-05 |
| 12144 | ADAM12 levels | GCST90468216 | 1.93e-05 |
| 12145 | IDP T1 SIENAX CSF normalised volume | GCST90002428 | 1.92e-05 |
| 12146 | Sleep apnea with BMI < 30 | GCST90624797 | 1.91e-05 |
| 12147 | MEGF9/MET ratio | GCST90315418 | 1.89e-05 |
| 12148 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5 | ECGA000005 | 1.89e-05 |
| 12149 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T30 | ECGA000030 | 1.85e-05 |
| 12150 | Subarachnoid haemorrhage | FING00001339 | 1.84e-05 |
| 12151 | IDP dMRI TBSS MO Superior corona radiata L | GCST90003977 | 1.84e-05 |
| 12152 | Spinal stenosis (PheCode 720) | GCST90476233 | 1.80e-05 |
| 12153 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11 | ECGA000011 | 1.78e-05 |
| 12154 | Trigger finger | FING00001376 | 1.77e-05 |
| 12155 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T463 | ECGU000463 | 1.68e-05 |
| 12156 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T233 | ECGA000233 | 1.65e-05 |
| 12157 | KIRREL2 levels | GCST90469690 | 1.63e-05 |
| 12158 | UNC5D levels | GCST90471010 | 1.63e-05 |
| 12159 | IDP T1 FAST ROIs L caudate | GCST90002549 | 1.62e-05 |
| 12160 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7 | ECGA000007 | 1.59e-05 |
| 12161 | potassium (maximum, inv-norm transformed) | GCST90476304 | 1.58e-05 |
| 12162 | DTI TBSS L1 Posterior thalamic radiation L | GCST90384457 | 1.58e-05 |
| 12163 | IDP dMRI TBSS ISOVF External capsule R | GCST90004509 | 1.53e-05 |
| 12164 | Menorrhagia | FING00000808 | 1.53e-05 |
| 12165 | Breathing problems during period of job | Employment history | UKBB00000111 | 1.52e-05 |
| 12166 | Takes medication for acid reflux/GERD? | GCST90475321 | 1.51e-05 |
| 12167 | Cysteine-glutathione disulfide levels | GCST90199784 | 1.44e-05 |
| 12168 | Attendance/disability/mobility allowance - None of the above | Other sociodemographic factors | UKBB00000059 | 1.43e-05 |
| 12169 | Arm fat mass (right) | Impedance measures | UKBB00000044 | 1.39e-05 |
| 12170 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T464 | ECGU000464 | 1.39e-05 |
| 12171 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320639 | 1.35e-05 |
| 12172 | Tibiofemoral angle | GCST90270263 | 1.32e-05 |
| 12173 | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite level | GCST90616403 | 1.30e-05 |
| 12174 | Addison's disease | GCST90011871 | 1.29e-05 |
| 12175 | Hypermetropia (PheCode 367.8) | GCST90475882 | 1.29e-05 |
| 12176 | EDA2R levels | GCST90469067 | 1.29e-05 |
| 12177 | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels | GCST90200033 | 1.25e-05 |
| 12178 | CPA1/CTRB1 ratio | GCST90314203 | 1.23e-05 |
| 12179 | Use of antiglaucoma preparations and miotics | FING00001409 | 1.22e-05 |
| 12180 | Alcohol intake versus 10 years previously | Alcohol | UKBB00000024 | 1.19e-05 |
| 12181 | Cataract | sense organs | UKBB00000120 | 1.18e-05 |
| 12182 | Internal derangement of knee (PheCode 835) | GCST90476282 | 1.18e-05 |
| 12183 | Descending aorta diameter | GCST90267391 | 1.14e-05 |
| 12184 | LAMP3/PRSS8 ratio | GCST90315275 | 1.14e-05 |
| 12185 | PLA2G1B levels | GCST90470246 | 1.13e-05 |
| 12186 | Lysophosphatidylcholine (24:0) [sn2] levels | GCST90025426 | 1.11e-05 |
| 12187 | ROBO2/SFTPD ratio | GCST90315785 | 1.11e-05 |
| 12188 | Hallux valgus (Bunion) | musculoskeletal | UKBB00000299 | 1.11e-05 |
| 12189 | Glucose (fasting status unknown, mean, inv-norm transformed) | GCST90475332 | 1.05e-05 |
| 12190 | aparc-Desikan rh thickness cuneus | GCST90003483 | 1.04e-05 |
| 12191 | Average log acceleration during the five least active hours of the day | GCST90061431 | 1.03e-05 |
| 12192 | Diverticulitis | GCST90468125 | 9.92e-06 |
| 12193 | Plantar fascial fibromatosis | FING00001169 | 9.85e-06 |
| 12194 | High-grade serous epithelial ovarian cancer | GCST90244168 | 9.72e-06 |
| 12195 | Bell pepper liking | GCST90094703 | 9.58e-06 |
| 12196 | CPB1/REG1A ratio | GCST90314212 | 9.57e-06 |
| 12197 | 3-amino-2-piperidone levels | GCST90200188 | 9.57e-06 |
| 12198 | Weight (mean, inv-normal transformed) | GCST90476463 | 9.31e-06 |
| 12199 | chloride (maximum, inv-norm transformed) | GCST90475192 | 9.26e-06 |
| 12200 | Urea levels (UKB data field 30670) | GCST90468108 | 9.10e-06 |
| 12201 | 1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels | GCST90200330 | 9.06e-06 |
| 12202 | Forearm length to body height ratio | GCST90270257 | 8.59e-06 |
| 12203 | chloride (mean, inv-norm transformed) | GCST90475194 | 8.58e-06 |
| 12204 | HippSubfield rh volume CA1-head | GCST90002696 | 8.45e-06 |
| 12205 | Indolelactate levels | GCST90243507 | 8.43e-06 |
| 12206 | Unstable angina pectoris | FING00001405 | 8.24e-06 |
| 12207 | A body shape index | GCST012231 | 7.97e-06 |
| 12208 | Other benign neoplasms of skin | FING00000971 | 7.97e-06 |
| 12209 | Diabetes (confirmatory factor analysis Factor 28) | GCST90309362 | 7.95e-06 |
| 12210 | aparc-DKTatlas lh thickness cuneus | GCST90003543 | 7.91e-06 |
| 12211 | Prostate cancer | GCST90274714 | 7.87e-06 |
| 12212 | Diabetes (standard GWA) | GCST90267278 | 7.84e-06 |
| 12213 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | GCST90004069 | 7.44e-06 |
| 12214 | Number of treatments/medications taken | Medications | UKBB00000542 | 7.42e-06 |
| 12215 | Cancer code, self-reported: prostate cancer (UKB data field 20001_1044) | GCST90041905 | 7.12e-06 |
| 12216 | SDHB levels | GCST90470561 | 7.11e-06 |
| 12217 | ROBO2/SCARF2 ratio | GCST90315784 | 6.58e-06 |
| 12218 | Cardiomyopathy | GCST90399705 | 6.14e-06 |
| 12219 | Ascending aorta strain | GCST90267388 | 6.03e-06 |
| 12220 | Vegetables liking | GCST90094862 | 5.93e-06 |
| 12221 | Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary Administration | UKBB00000837 | 5.76e-06 |
| 12222 | CPA1/CPB1 ratio | GCST90314202 | 5.70e-06 |
| 12223 | T1 FreeSurfer BA rh BA3a exvivo thickness | GCST90385563 | 5.70e-06 |
| 12224 | Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary Operations | UKBB00000583 | 5.65e-06 |
| 12225 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8 | ECGA000008 | 5.51e-06 |
| 12226 | Treatment/medication code - lansoprazole | Medications | UKBB00000848 | 5.35e-06 |
| 12227 | DTI TBSS MD Posterior limb of internal capsule R | GCST90384590 | 5.32e-06 |
| 12228 | IDP dMRI ProbtrackX OD str l | GCST90004473 | 5.25e-06 |
| 12229 | Chronic Kidney Disease, Stage III (PheCode 585.33) | GCST90476128 | 5.19e-06 |
| 12230 | Pain and other conditions associated with female genital organs and menstrual cycle | FING00001136 | 5.04e-06 |
| 12231 | Blood urea nitrogen levels | GCST90278623 | 4.99e-06 |
| 12232 | Calculus of kidney and ureter | FING00000236 | 4.77e-06 |
| 12233 | Prostate cancer | GCST90274716 | 4.75e-06 |
| 12234 | SEPTIN8 levels | GCST90470578 | 4.63e-06 |
| 12235 | Benign neoplasm: Colon, unspecified | FING00000172 | 4.53e-06 |
| 12236 | DTI TBSS L1 External capsule R | GCST90384460 | 4.47e-06 |
| 12237 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4 | ECGA000004 | 4.34e-06 |
| 12238 | Frailty (Factor 6 - Disability) | GCST90624052 | 4.23e-06 |
| 12239 | HippSubfield rh volume CA3-body | GCST90002702 | 4.15e-06 |
| 12240 | Lung function (FEV1/FVC) | GCST007431 | 4.01e-06 |
| 12241 | Operative procedures - Unspecified diagnostic endoscopic examination of colon | Summary Operations | UKBB00000591 | 3.99e-06 |
| 12242 | Aneurysm of iliac artery (PheCode 442.2) | GCST90475995 | 3.94e-06 |
| 12243 | Benign neoplasm of colon, rectum, anus and anal canal | FING00000155 | 3.76e-06 |
| 12244 | GSTT2B levels | GCST90469415 | 3.55e-06 |
| 12245 | aparc-Desikan lh thickness cuneus | GCST90003449 | 3.52e-06 |
| 12246 | Other disorders of eyelids (PheCode 374) | GCST90475890 | 3.52e-06 |
| 12247 | N6,N6-dimethyllysine levels in chronic kidney disease | GCST90257529 | 3.50e-06 |
| 12248 | SERPINI2 levels | GCST90470603 | 3.28e-06 |
| 12249 | PNLIPRP1 levels | GCST90470273 | 3.24e-06 |
| 12250 | Psoriatic arthritis vs Cutaneous psoriasis | GCST90243957 | 3.19e-06 |
| 12251 | Non-mucinous epithelial ovarian cancer | GCST90244167 | 3.09e-06 |
| 12252 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T445 | ECGU000445 | 2.76e-06 |
| 12253 | Prostate cancer | GCST90475185 | 2.73e-06 |
| 12254 | Arm fat percentage left (UKB data field 23123) | GCST90468157 | 2.65e-06 |
| 12255 | Butternut squash liking | GCST90094718 | 2.56e-06 |
| 12256 | aparc-DKTatlas rh thickness cuneus | GCST90003574 | 2.49e-06 |
| 12257 | rfMRI connectivity (ICA100 edge 951) | GCST90005804 | 2.42e-06 |
| 12258 | Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers) | FING00000770 | 2.41e-06 |
| 12259 | COL6A3 levels | GCST90468821 | 2.29e-06 |
| 12260 | Frequency of drinking alcohol | Alcohol use | UKBB00000260 | 2.17e-06 |
| 12261 | Phospholipids to Total Lipids in Small LDL percentage | GCST90499690 | 2.15e-06 |
| 12262 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T10 | ECGA000010 | 2.11e-06 |
| 12263 | Own or rent accommodation lived in - Own outright (by you or someone in your household) | Household | UKBB00000623 | 2.00e-06 |
| 12264 | Prostate cancer | GCST90428117 | 1.79e-06 |
| 12265 | Total thigh muscle volume z-score | GCST90267356 | 1.67e-06 |
| 12266 | Arm fat percentage right (UKB data field 23119) | GCST90468158 | 1.66e-06 |
| 12267 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T39 | ECGA000039 | 1.63e-06 |
| 12268 | Volume of right anterior amygdaloid area | GCST90475003 | 1.61e-06 |
| 12269 | Cancer code, self-reported: breast cancer (UKB data field 20001_1002) | GCST90041886 | 1.61e-06 |
| 12270 | DDR1/SFTPD ratio | GCST90314443 | 1.57e-06 |
| 12271 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T232 | ECGA000232 | 1.44e-06 |
| 12272 | Campesterol levels | GCST90199725 | 1.30e-06 |
| 12273 | aparc-a2009s rh thickness Pole-occipital | GCST90003718 | 1.26e-06 |
| 12274 | HMOX2 levels | GCST90469466 | 1.24e-06 |
| 12275 | Elevated prostate specific antigen [PSA] (PheCode 796) | GCST90476277 | 1.22e-06 |
| 12276 | Prostate cancer | GCST90018685 | 1.11e-06 |
| 12277 | Leg fat percentage right (UKB data field 23111) | GCST90468175 | 1.06e-06 |
| 12278 | CD59 levels | GCST90468639 | 1.04e-06 |
| 12279 | Cancer of prostate (PheCode 185) | GCST90475591 | 9.83e-07 |
| 12280 | Leg fat percentage left (UKB data field 23115) | GCST90468174 | 9.06e-07 |
| 12281 | Leg fat percentage (left) | Impedance measures | UKBB00000391 | 9.03e-07 |
| 12282 | Breathing problems responsible for leaving job | Employment history | UKBB00000112 | 6.96e-07 |
| 12283 | aparc-a2009s lh volume S-central | GCST90002969 | 6.62e-07 |
| 12284 | CD3 on Terminally Differentiated CD4+ T cell | GCST90001844 | 6.60e-07 |
| 12285 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9 | ECGA000009 | 6.43e-07 |
| 12286 | aseg lh volume Lateral-Ventricle | GCST90002616 | 6.26e-07 |
| 12287 | Uterine fibroids | GCST90461958 | 6.00e-07 |
| 12288 | HippSubfield rh volume Whole-hippocampus | GCST90002711 | 5.60e-07 |
| 12289 | Joint pain (confirmatory factor analysis Factor 14) | GCST90309348 | 5.51e-07 |
| 12290 | aparc-a2009s rh area G-pariet-inf-Supramar | GCST90003396 | 5.47e-07 |
| 12291 | Other heart diseases | FING00001057 | 4.04e-07 |
| 12292 | Operative procedures - Fibreoptic endoscopic snare resection of lesion of colon | Summary Operations | UKBB00000579 | 3.98e-07 |
| 12293 | COQ7 levels | GCST90468831 | 3.34e-07 |
| 12294 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T37 | ECGA000037 | 2.86e-07 |
| 12295 | TIGIT levels | GCST90470865 | 2.60e-07 |
| 12296 | IDP dMRI ProbtrackX L1 str l | GCST90004269 | 2.54e-07 |
| 12297 | Thoracic aortic aneurysm | FING00001357 | 2.35e-07 |
| 12298 | Breast cancer | GCST010098 | 2.01e-07 |
| 12299 | GAST levels | GCST90469307 | 1.62e-07 |
| 12300 | Leg fat percentage (right) | Impedance measures | UKBB00000392 | 1.59e-07 |
| 12301 | T1 CAT volume L LateralOccipitalCortexinferiordivision | GCST90384044 | 1.55e-07 |
| 12302 | Blood urea nitrogen (BUN, maximum, inv-norm transformed) | GCST90475162 | 1.24e-07 |
| 12303 | Arm fat percentage (right) | Impedance measures | UKBB00000046 | 8.66e-08 |
| 12304 | Arm fat percentage (left) | Impedance measures | UKBB00000045 | 8.22e-08 |
| 12305 | GPHA2 levels | GCST90469389 | 7.48e-08 |
| 12306 | Hypertensive Heart Disease | FING00000639 | 5.78e-08 |
| 12307 | GPLD1 levels | GCST90086890 | 5.37e-08 |
| 12308 | Benign lipomatous neoplasm | FING00000146 | 4.01e-08 |
| 12309 | BA-exvivo lh volume BA3a | GCST90002837 | 3.39e-08 |
| 12310 | Prostate cancer | GCST006085 | 3.08e-08 |
| 12311 | Normotensive glaucoma | FING00000892 | 2.33e-08 |
| 12312 | Body fat percentage | Impedance measures | UKBB00000102 | 2.03e-08 |
| 12313 | Long-standing illness, disability or infirmity | General health | UKBB00000409 | 2.04e-09 |